MedPath

MORPHINE SULPHATE INJECTION,USP LIQ 1.1MG/ML

MORPHINE SULPHATE INJECTION,USP LIQ 1.1MG/ML

Discontinued
DIN Number

02010364

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

International Medication Systems Ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02010364
AIG Number0104545004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous ,  Refer (See Dosage Form)
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

MORPHINE SULFATEActive
Strength: 1.1 MG / ML
Monograph: MORPHINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.